Considering the above-mentioned functions and effects of SAV1, to determine the feasibility of SAV1 as a gene therapy target for lung cancer, a lentivirus-mediated SAV1 gene transfer lung organoid model was established using clinical tissue samples. This evidence concerns the gene SAV1 and lung carcinoma.